American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …

K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials

C Patikorn, K Roubal, SK Veettil, V Chandran… - JAMA network …, 2021 - jamanetwork.com
Importance Several meta-analyses of randomized clinical trials (RCTs) have demonstrated
the many health benefits of intermittent fasting (IF). However, there has been little synthesis …

Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial

M Ezpeleta, K Gabel, S Cienfuegos, F Kalam, S Lin… - Cell metabolism, 2023 - cell.com
Innovative non-pharmacological lifestyle strategies to treat non-alcoholic fatty liver disease
(NAFLD) are critically needed. This study compared the effects of alternate day fasting (ADF) …

Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors

O Juanola, S Martínez-López, R Francés… - International journal of …, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …

[HTML][HTML] The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta …

L Haigh, C Kirk, K El Gendy, J Gallacher, L Errington… - Clinical Nutrition, 2022 - Elsevier
Background & aims Lifestyle interventions that focus on reduced energy intake and
improved dietary pattern are the mainstay of non-alcoholic fatty liver disease (NAFLD) …

[HTML][HTML] Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet–a randomised controlled trial

M Holmer, C Lindqvist, S Petersson… - JHEP Reports, 2021 - Elsevier
Background & Aims The first-line treatment for non-alcoholic fatty liver disease (NAFLD) is
weight reduction. Several diets have been proposed, with various effects specifically on liver …

Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease

SR Sharpton, B Schnabl, R Knight, R Loomba - Cell metabolism, 2021 - cell.com
Nonalcoholic fatty liver disease (NALFD) is now a leading cause of chronic liver disease
worldwide, in part, as a consequence of rapidly rising levels of obesity and metabolic …

Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

T Fernandez, M Vinuela, C Vidal, F Barrera - PloS one, 2022 - journals.plos.org
Background Non-alcoholic fatty liver disease is a liver condition that is increasing worldwide
and expected to become the number one cause of cirrhosis and hepatocellular carcinoma in …

Emerging role of hepatic ketogenesis in fatty liver disease

RGR Mooli, SK Ramakrishnan - Frontiers in Physiology, 2022 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver diseases, arise
from non-alcoholic fatty liver (NAFL) characterized by excessive fat accumulation as …

[HTML][HTML] Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis

C Yin, Z Li, Y Xiang, H Peng, P Yang, S Yuan… - Frontiers in …, 2021 - frontiersin.org
Background: Weight loss by lifestyle modification is the cornerstone therapy of non-alcoholic
fatty liver disease. Intermittent fasting has shown favorable effects on body weight and …